Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
27,784,592
Share change
+207,449
Total reported value
$3,965,954,154
Put/Call ratio
143%
Price per share
$142.77
Number of holders
194
Value change
+$70,956,802
Number of buys
101
Number of sells
91

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2020

As of 31 Dec 2020, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 194 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,784,592 shares. The largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, KPS Global Asset Management UK Ltd, Alua Capital Management LP, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and LORD, ABBETT & CO. LLC. This page lists 194 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.